Gregory P. Hanson
2016 - MabVax Therapeutics Holdings
In 2016, Gregory P. Hanson earned a total compensation of $476.9K as Chief Financial Officer at MabVax Therapeutics Holdings, a 78% decrease compared to previous year.
Compensation breakdown
| Bonus | $62,790 |
|---|---|
| Option Awards | $99,743 |
| Salary | $299,342 |
| Other | $15,055 |
| Total | $476,930 |
Hanson received $299.3K in salary, accounting for 63% of the total pay in 2016.
Hanson also received $62.8K in bonus, $99.7K in option awards and $15.1K in other compensation.
Rankings
In 2016, Gregory P. Hanson's compensation ranked 11,358th out of 14,075 executives tracked by ExecPay. In other words, Hanson earned more than 19.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,358 out of 14,075 | 19th |
Division Manufacturing | 4,420 out of 5,486 | 19th |
Major group Chemicals And Allied Products | 1,587 out of 1,900 | 17th |
Industry group Drugs | 1,282 out of 1,543 | 17th |
Industry Pharmaceutical Preparations | 995 out of 1,173 | 15th |
Source: SEC filing on May 2, 2017.
Hanson's colleagues
We found three more compensation records of executives who worked with Gregory P. Hanson at MabVax Therapeutics Holdings in 2016.